Apr 19, 2018 - US equity markets are an attractive source of capital and liquidity, even for companies that are already listed on foreign exchanges or the OTC markets. Frankfurt-listed MorphoSys (NASDAQ:MOR) began t
Apr 17, 2018 - A closely-watched showdown at the U.S. Supreme Court today will determine whether states can force out-of-state online retailers to collect sales tax. South Dakota is asking the nine justices to over
Apr 10, 2018 - Recent acquisitions and clinical trial stumbles show the high-risk, high-return nature of biotech IPOs. Betting on a biotech buyout. The billion-dollar biotech buyouts continue. News broke on Monday t
Mar 29, 2018 - Baker Bros. Advisors Lp Buys Biomarin Pharmaceutical Inc, Ablynx NV, Erytech Pharma, Sells Advanced Accelerator Applications SA, Achaogen Inc, NeuroDerm, Stocks: BMRN,ARGX,MDGL,SAGE,NBIX,GWPH,ABLX,ERYP,RYTM,NKTR,, release date:Mar 29, 2018
Feb 22, 2018 - Ablynx NV (OTCPK:ABLYF): FY Net loss of €108.5MRevenue of €55.5M (-34.9% Y/Y)Press Release
Feb 19, 2018 - AbbVie’s promising pipeline. Johnson & Johnson’s Tremfya data promising. Celgene reports positive results in phase 2 trial of Otezla.
Feb 02, 2018 - Novel gene-therapy innovator (Solid Biosciences) continued its rally.With the promising molecule (entinostat), Syndax Pharmaceuticals extended its gain for the month.Recent Sanofi acquisition of Ablyn
Jan 31, 2018 - On Jan. 29, Sanofi announced it would be acquiring Ablynx; the smaller biotech had previously rebuffed a lower offer from Novo Nordisk.Ablynx shareholders will be rewarded with a solid premium and San
Jan 30, 2018 - The following slide deck was published by Sanofi in conjunction with this event.
Jan 30, 2018 - Small pullback in S&P 500 but biotech indexes continued the uptrend.Sanofi acquired Ablynx for $4.8B for its nanobody platform.PTC Therapeutics released early intrim data in SMA type 1.More insights o